FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Charuvastra Anthony 2. Date of Event Requiring Statement (MM/DD/YYYY)
3/26/2015 

3. Issuer Name and Ticker or Trading Symbol Targeted Medical Pharma, Inc. [TRGM]
(Last)        (First)        (Middle)
200 PARK AVE. SOUTH SUITE 1118 B
4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                            ___ X ___ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)
(Street)
NEW YORK,, NY 10003       
(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   3422748   I   By Elizabeth Charuvastra Marital Trust   (1)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
( 1)  Mr. Charuvastra is Trustee of the Elizabeth Charuvastra Marital Trust and may be considered to have beneficial ownership. Mr. Charuvastra disclaims beneficial ownership of any shares in which she does not have a pecuniary interest.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Charuvastra Anthony
200 PARK AVE. SOUTH SUITE 1118 B
NEW YORK,, NY 10003

X


Signatures
/s/ Anthony Charuvastra 4/22/2016
** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Targeted Medical Pharma (PK) (USOTC:TRGM)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more Targeted Medical Pharma (PK) Charts.
Targeted Medical Pharma (PK) (USOTC:TRGM)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more Targeted Medical Pharma (PK) Charts.